Latin America Infusion Pumps Market Size, Share, Industry, Forecast and outlook (2024-2031)

Latin America Infusion Pumps Market is segmented By Product Type (Implantable Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Volumetric Infusion Pumps, Others), By Application (Diabetes, Chemotherapy/Oncology, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others), By End-User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings, Academic & Research Institutes, Others) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Report Overview

Latin America Infusion Pumps Market reached US$ 106.90 million in 2023 and is expected to reach US$ 180.50 million by 2031, growing at a CAGR of 6.9% during the forecast period 2024-2031.

Infusion pumps are utilized extensively in the home and clinical environments such as nursing homes and hospitals. In contrast to manual administration, they provide numerous benefits, including the ability to administer fluids in minute quantities and at precisely programmed or automated intervals. They are utilized to administer medications or nutrients, including antibiotics, insulin or other hormones, painkillers, and chemotherapy medicines. 

Infusion pumps allow for highly viscous medications to be administered through small catheters into the veins. Medication is usually administered this way through the dorsal veins of the hand, the forearm, the arm, the dorsal veins of the foot, the inguinal region and the antecubital fossa.

Market Scope

For more details on this report – Request for Sample

Market Dynamics: Drivers & Restraints

Increasing prevalence of chronic diseases

The rising chronic diseases are expected to drive the market growth. Rising chronic diseases are expected to increase the demand for infusion pumps to maintain the body fluids concentrations. 

For instance, according to a report published by the National Institue of Health in 2023, during the three years (2023–2025), a total of 704,000 new cases of cancer occur each year in the country, excluding non-melanoma skin cancer, an estimated 244,000 occur in women and 239,000 in men. 70% of cases are expected for the South and Southeast regions. Breast cancer in women, prostate cancer, and colon and rectum are the three most frequent types in these two regions.

The increasing prevalence of chronic disorders due to the rapid growth of the geriatric population is increasing the use of infusion products in home care as well as hospitals. Thus, the above factors are expected to contribute to the growth of the Latin American infusion pump market.

Regulatory hurdles

Regulatory limitations involved with approving infusion pumps are projected to hinder industry growth. Ensuring that infusion pumps meet tight regulatory requirements pays significant costs. These can include costs for clinical investigations, paperwork, quality control procedures, and GMP compliance. Startups and smaller companies could find these expenses too costly.

Market Segment Analysis

The Latin America infusion pumps market is segmented based on product type, application, and end-user.

Insulin infusion pumps segment is expected to dominate the market share

Insulin infusion pumps hold a significant portion of the market share and are expected to continue throughout the forecast period. This is due to the increasing adoption of infusion pumps in the treatment of diabetic patients. The growing number of diabetic patients is also expected to be one of the major factors for the increasing demand for infusion pumps. 

According to a report published by the National Institute of Health in 2024, it is stated that the prevalence of diabetes in Brazil is on the rise, with an estimated five million individuals currently affected by the disease. This number is expected to increase to 11 million by 2040. 

With the increasing number of diabetic population, the demand for insulin infusion pumps is expected to rise which could contribute to the segment’s expansion.  Thus, the above factors are expected to drive the segment growth and are expected to hold the segment in the dominant position.

Market Segmentation

By Product Type

• Implantable Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Volumetric Infusion Pumps
• Others 

By Application

• Diabetes
• Chemotherapy/Oncology
• Gastroenterology
• Analgesia/Pain Management
• Pediatrics/Neonatology
• Hematology
• Others

By End-User

• Hospitals & Clinics
• Ambulatory Care Settings
• Home Care Settings
• Academic & Research Institutes
• Others

Market Competitive Landscape

The major players in the market include Terumo Corporation, Biomedix Medical, Inc., B. Braun Medical, Nareena Lifesciences Private Limited, Becton, Dickinson and Company, Medtronic plc, Merck KGaA and Nipro Medical Corporation among others.

Why Purchase the Report?

• To visualize the Latin America infusion pumps market segmentation based on product type, application, and end-user, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of infusion pumps market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The Latin America infusion pumps market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies